Login
$PEPG
$4.19 +$0.00 (0.0%) After hours

$PEPG SEC Filings

Filed On Filing
12 Nov 2026 8-K: Entry into a Material Definitive Agreement; Other Events

PepGen Inc., a Delaware corporation (the “Company”), confirms its agreement with Leerink Partners LLC (“Leerink Partners”), Stifel, Nicolaus & Company, Incorporated (“Stifel”), Guggenheim Securities, LLC (“Guggenheim Securities”) and eac...

12 Nov 2026 424B5
10 Nov 2026 424B5
10 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more

Positive FREEDOM2-DM1 10 mg/kg cohort results demonstrated highest reported splicing correction and improvements across multiple functional measures –

10 Nov 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more

– DSMB recommends advancement of PGN-EDODM1 into the highest dose cohort in the FREEDOM2-DM1 study, as well as FREEDOM-OLE dose escalation from 5 mg/kg to 10 mg/kg –

06 Aug 2026 10-Q
22 Jun 2026 Form 4: Ra Capital MANAGEMENT, L.p., Director and 4 others

Granted 34,000 Stock Option (Right to Buy)

22 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

The 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) of PepGen Inc. (the “Company”) was held on June 18, 2026. The proposals set forth below were submitted to the stockholders at the 2026 Annual Meeting, with each such pro...

22 Jun 2026 Form 4: Wyman Lisa, Director

Granted 34,000 Stock Option (Right to Buy)

22 Jun 2026 Form 4: Resnick Joshua, Director

Granted 34,000 Stock Option (Right to Buy)

22 Jun 2026 Form 4: Mayer Howard, Director

Granted 34,000 Stock Option (Right to Buy)

22 Jun 2026 Form 4: Finer Mitchell H., Director

Granted 34,000 Stock Option (Right to Buy)

22 Jun 2026 Form 4: Dable Habib J, Director

Granted 34,000 Stock Option (Right to Buy)

22 Jun 2026 Form 4: Henson Heidi, Director

Granted 34,000 Stock Option (Right to Buy)

22 Jun 2026 Form 4: Keating Laurie, Director

Granted 34,000 Stock Option (Right to Buy)

26 May 2026 Form 4: Kasraian Kasra, Chief Technical Officer

Sold 1,233 shares ($1.74K)

21 May 2026 EFFECT
21 May 2026 8-K: Regulation FD Disclosure

Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may be identified by words such as “aims,” “anticip...

19 May 2026 CORRESP

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support